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Abstract
Background: Dolichospermum circinale is a filamentous bloom-forming cyanobacterium responsible for biosynthesis
of the paralytic shellfish toxins (PST), including saxitoxin. PSTs are neurotoxins and in their purified form are important
analytical standards for monitoring the quality of water and seafood and biomedical research tools for studying neuronal
sodium channels. More recently, PSTs have been recognised for their utility as local anaesthetics. Characterisation of the
transcriptional elements within the saxitoxin (sxt) biosynthetic gene cluster (BGC) is a first step towards accessing these
molecules for biotechnology.
Results: In D. circinale AWQC131C the sxt BGC is transcribed from two bidirectional promoter regions encoding five
individual promoters. These promoters were identified experimentally using 5′ RACE and their activity assessed via
coupling to a lux reporter system in E. coli and Synechocystis sp. PCC 6803. Transcription of the predicted drug/metabolite
transporter (DMT) encoded by sxtPER was found to initiate from two promoters, PsxtPER1 and PsxtPER2. In E. coli, strong
expression of lux from PsxtP, PsxtD and PsxtPER1 was observed while expression from Porf24 and PsxtPER2 was remarkably
weaker. In contrast, heterologous expression in Synechocystis sp. PCC 6803 showed that expression of lux from PsxtP,
PsxtPER1, and Porf24 promoters was statistically higher compared to the non-promoter control, while PsxtD showed poor
activity under the described conditions.
Conclusions: Both of the heterologous hosts investigated in this study exhibited high expression levels from three of the
five sxt promoters. These results indicate that the majority of the native sxt promoters appear active in different
heterologous hosts, simplifying initial cloning efforts. Therefore, heterologous expression of the sxt BGC in either
E. coli or Synechocystis could be a viable first option for producing PSTs for industrial or biomedical purposes.
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Background
Saxitoxin (STX) is a neurotoxin produced by cyanobac-
teria and dinoflagellates and is a member of the broader
group of alkaloids known as the paralytic shellfish toxins
(PSTs) [1]. When high concentrations of PSTs are con-
sumed by humans, acute poisoning can lead to death
due to respiratory paralysis [2–4]. Therefore, PSTs are
needed as analytical standards for the monitoring and
protection of commercial seafood and freshwater reser-
voirs, as well as for use in biomedical research. While
the PSTs pose a significant public health risk and eco-
nomic burden on society during algal bloom events,
their scientific and pharmaceutical potential is well
known [3, 4]. Purified PSTs have been a critical tool for
researchers investigating neuronal sodium channels,
where the toxins specifically block site 1 of voltage-gated
sodium channels [5]. Under controlled administration,
PSTs are potent anaesthetics, particularly in combin-
ation with other local anaesthetics [6, 7]. Further at-
tempts to utilise STX in clinical trials are hindered by its
toxicity, but more recent approaches, such as generating
liposomal formulations of STX, resulted in blockage of
the sciatic nerves in rats with no myotoxic, cytotoxic or
neurotoxic effects [8]. It has been postulated that the
same delivery could provide effective localised treatment
for severe joint pain [9]. Other PSTs, such as the
gonyautoxins (GTXs), also have clinical potential and
have been utilised for the treatment of anal fissures and
chronic tension type headaches [10–12].
Obtaining significant quantities of purified PSTs for clin-
ical research or water quality analysis is difficult. Chemical
synthesis and biocatalytic synthesis of PSTs is complex, dif-
ficult to scale up and may not produce all relevant naturally
occurring isoforms [13, 14], The most common form of
obtaining purified compounds involves extraction and iso-
lation from dinoflagellate blooms, cyanobacterial cultures
or contaminated shellfish coupled with synthetic conver-
sion to additional PSTs [15–17]. Analytical calibration stan-
dards are commercially available from the National
Research Council Canada (NRC), which are obtained from
extractions of PST producing dinoflagellates or contami-
nated shellfish, and in some instances, semi-synthetic con-
versions of PSTs are required to obtain or broad array of
analogues. Thus, the process is difficult, inefficient and
costly [18]. These issues clearly highlight the need for an
alternative and reliable method for the production and
purification of commercial quantities of PSTs.
Heterologous expression of cyanobacterial biosynthetic
gene clusters (BGCs) is not well established in compari-
son to heterologous expression of Actinomycete BGCs.
Streptomyces expression hosts successfully produced
more than 90 Actinomycete NPs, most of which are het-
erologously expressed using native promoters [19]. On
the other hand, only 10 cyanobacterial NPs have been
successfully produced from heterologous systems using
both native and heterologous promoters [20], highlight-
ing the need to better understand the function of native
promoters in heterologous hosts. E. coli is a suitable host
for the heterologous expression of cyanobacterial path-
ways based on its fast growth rate as previously demon-
strated [21, 22]. Initial studies used native promoters to
produce the ribosomal peptides patellamide A and C,
and the microviridins [23, 24]. Recently, there has been
a focus on the heterologous expression of cyanobacterial
natural product BGCs including the lyngbyatoxin (ltx)
BGC in E. coli using the tetracycline-inducible PtetO pro-
moter [21, 25]. The ltx BGC has been the focus of mul-
tiple heterologous expression studies due to its relatively
small size. It has also been expressed in the cyanobacter-
ium Anabaena sp. PCC 7120, and E. coli GB05-MtaA
[26, 27]. While the native ltx promoters were active in
Anabaena sp. PCC 7120 and drive the production of
lyngbyatoxin A, the native promoters were not active in
E. coli. The addition of Anabaena sp. PCC 7120 sigma
factors to the E. coli host also failed to induce expression
of lyngbyatoxin A, suggesting that the heterologous host
was unable to recognise the cyanobacterial ribosome
binding sites [28]. Subsequently, titres of lyngbyatoxin A
close to the native producer were achieved when using
the cyanobacterium Anabaena sp. PCC 7120 as a heter-
ologous host [26]. This highlights that discrepancies be-
tween cyanobacterial promoter efficiencies in different
host organisms remain poorly understood. Therefore, it
is beneficial to test the activity of promoters in heterol-
ogous hosts and expression vectors using reporter
systems prior to cloning complex biosynthetic pathways
for biotechnological applications [29].
For the most part, cyanobacterial transcription ma-
chinery is similar to that found in E. coli, with the main
difference being the widespread absence of the − 35 hex-
amer in cyanobacteria, which is believed to be replaced
by a transcription factor binding site to initiate tran-
scription [30]. In E. coli, σ70 is able to recognise the ma-
jority of promoters while in cyanobacteria, a range of
different sigma factors have been identified [31, 32].
The saxitoxin (sxt) BGC has been characterised in six
cyanobacterial species from the order Nostocales and one
from the order Oscillatoriales [33–37]. Each sxt BGC en-
codes a ‘core’ set of enzymes putatively responsible for
STX biosynthesis, supplemented with ‘tailoring’ and ‘auxil-
iary’ genes that give rise to PST analogues or perform
functions after PST biosynthesis. Information regarding
the regulation of transcriptional elements of cyanobacter-
ial secondary metabolite biosynthesis remains limited to
the microcystin (mcy) and jamaicamide (jam) BGCs [38–
43]. However, the regulation of PSTs at the molecular
level, including the transcriptional elements of the sxt
BGC remains largely unknown [44, 45].
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Here, we identify the transcription units of the sxt
BGC within the cyanobacterium Dolichospermum circi-
nale AWQC131C which enabled the experimental isola-
tion of five promoter regions. We then assessed the
reliability of a luciferase reporter (lux) system to assay
the activity of uncharacterised cyanobacterial promoters
in the heterologous hosts E. coli and Synechocystis sp.
PCC 6803 for the first time. Characterisation of these
cyanobacterial promoters and determination of their activ-
ity in E. coli and Synechocystis, highlights the unpredict-
ability of cyanobacterial promoters of natural product
BGCs in heterologous hosts. This study is the first essen-
tial phase of understanding the cloning strategy expression
of PST biosynthesis, identifying the need for promoter en-
gineering or exchange in future experiments.
Results
Identification of transcriptional units within the sxt
biosynthetic gene cluster
Reverse-transcriptase PCR revealed that the sxt BGC in
D. circinale AWQC131C is transcribed as five transcrip-
tional units from two bidirectional promoter regions
(Fig. 1; Additional file 1: Figure S1). All five transcripts
appear to be constitutively expressed under standard la-
boratory conditions, since sxt mRNA was detected
across all time points. Operon 1, sxtDV*EABC (* indi-
cates disrupted ORF of sxtV [34]), spans 7.3 kb, is tran-
scribed in the reverse direction and encodes several
proteins predicted to be involved early in PST biosyn-
thesis. Operon 2, sxtPQR, spans 3.5 kb and is transcribed
in the forward direction. The catalytic functions of SxtP,
SxtQ and SxtR are unknown, but they are likely to be
essential for PST biosynthesis as their presence and or-
ganisation is conserved amongst all reported sxt clusters.
The third transcriptional unit is monocistronic and en-
codes SxtPER, a putative permease of the drug/metabol-
ite transporter family of proteins and is transcribed from
two promoters, as discussed further below. Operon 4, is
transcribed in the forward direction and spans 12.8 kb.
Operon 4 encodes a protein of unknown function, Orf24
that is conserved in most sxt clusters, followed by genes
encoding 12 enzymes involved in PST biosynthesis,
resulting in the polycistron orf24sxtSTUNGHMIJKLO.
The 3′ ends of operons 1–4 were bioinformatically
screened for putative Rho-dependent and Rho-independent
transcriptional termination sites using the programs
TransTerm and TranstermHP, respectively [46, 47]. Rho-
independent transcription termination sites were identified
in the non-coding regions of three out of four sxt mRNA
transcripts (Additional file 1: Table S1). Rho-dependent or
Rho-independent termination sites were not identified in
the sequence of mRNA encoding operon 1.
Transcription start sites and promoter regions of the sxt
operons
The transcriptional start sites (TSSs) of each operon
were experimentally identified via 5′ rapid amplification
of cDNA ends (5′ RACE) (Table 1; Additional file 1:
Figure S2). The upstream region of each TSS was
screened for a promoter sequence consistent with con-
served binding sequences of group 1, 2 and 3 sigma fac-
tors [31]. All promoters identified in this study displayed
sequence similarity to the consensus − 10 hexamer
(Pribnow box) of the prokaryotic RNA polymerase
Fig. 1 Transcriptional analysis of the D. circinale AWQC131C sxt cluster. Genes required for PST biosynthesis are transcribed by a minimum of four
mRNA transcripts from two bi-directional promoter regions encoding five promoters; PsxtD (operon 1), PsxtP (operon 2), PsxtPER1 (TU 3), PsxtPER2
(TU 3) and Porf24 (operon 4). Direction of transcription is indicated by black arrows
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binding site, while there was sporadic presence of the −
35 hexamer binding site (Table 1). These results suggest
that the sxt promoters of D. circinale AWQC131C are
activated by an RNA polymerase core enzyme in con-
junction with a group 1 or group 2 sigma factor [31, 48].
For the − 10 promoter sequences identified, a search was
conducted for an extended − 10 binding site and up-
stream (UP) element. The 5′ untranslated region (UTR)
of each operon was also bioinformatically screened for
the presence of consensus ribosomal binding site (RBS)
sequences, although previously reported bioinformatics
surveys of cyanobacterial genomes were not able to
identify the consensus RBS sequence in all genes [49,
50]. Based on the 5′ RACE and bioinformatics data, the
D. circinale AWQC131C sxt BGC includes of a total of
five TSSs under standard culture conditions (Fig. 2).
Table 1 Characteristics of promoter regions in the sxt biosynthetic gene cluster of D. circinale AWQC131C
Promoter Promoter sequence 5′ ➔ 3′ PositionΔ
PsxtD tgtcTTGTGG....(14 bp).....GAgTATACTtgactagtA −32
PsxtP gtatCTATCA....(12 bp).....GTgTATACTagtcaagtA −34
PsxtPER1 ttccTTGCAA....(15 bp).....AGtTACAATtacatgA −91
PsxtPER2 tgagATGACA....(21 bp).....CGaTATATTttgggtG + 94
Porf24 aaaaTTTCCT....(15 bp).....TGcTATAATgaaatcT −160
E. coli σ70 consensus ....TTGACA....(14 bp).....TGnTATAAT......N
The −10 and − 35 hexamers are capitalised and conserved nucleotides are in bold print. N indicates transcriptional start site (TSS). Δ Position of promoter relative
to TSS
Fig. 2 Sequence analysis of the five promoters present within the D. circinale AWQC131C sxt biosynthetic gene cluster. a Intergenic between sxtD and
sxtP showing the bidirectional promoter region of operon 1 and 2. b Intergenic between sxtPER and orf24 showing the bidirectional promoter region
of operon 3 and 4. Individual promoters include, PsxtD (green), PsxtP (red), PsxtPER2 (light blue), PsxtPER1 (dark blue) and Porf24 (yellow). Transcriptional
elements including promoters, TSS, translation start site, and RBS are shown for the five sxt promoters
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Operon 1 (sxtDV*EABC) contains a short 5′ UTR of −
32 bp upstream of the translation start site and a promoter
(PsxtD) with high sequence similarity to the E. coli σ70–10
and − 35 hexamers. PsxtP initiates the transcription of op-
eron 2, possesses a short 5′ UTR spanning 34 bp and con-
tains both − 10 and − 35 regions. The transcript initiated
by PsxtP also displayed a likely RBS (AAGA) 6 nucleotides
upstream of the sxtP translation start site. A conserved − 35
sequence was also identified 21 bp upstream of the extended
− 10 sequence, resulting in an unusually long distance be-
tween the two hexamers. Porf24 has a perfectly conserved −
10 consensus sequence, including the extended − 10 TGn
motif (Table 1). The 5′ UTR for orf24 is 160 bp in length.
Unusually, transcription of the putative transporter,
sxtPER, was initiated from two promoters, PsxtPER1 and
PsxtPER2. PsxtPER1 is located 91 bp upstream of the an-
notated TSS of sxtPER (Fig. 2) and contains a highly
conserved − 10 and − 35 RNA polymerase binding site.
PsxtPER2 is located 94 bp downstream of the transla-
tional start site and contains a highly conserved − 10 se-
quence, including the single nucleotide seen in extended
− 10 promoters as well as an RBS (AAAGAAG).
The activity of sxt promoters in E. coli
The five promoters identified in the D. circinale sxt clus-
ter using 5′ RACE, PsxtP, PsxtD, PsxtPER1, PsxtPER2
and Porf24, were amplified by PCR and cloned into the
E. coli expression vector, pET28b (Novagen), directly in
front of a lux operon (Additional file 1: Figure S4).
Expression of luciferase from each of these promoters was
measured and compared with negative controls; pET28-lux
harbouring a non-promoter region from within the sxtO
gene and the pET28-lux plasmid with no added promoter.
Unpaired t-tests showed that all promoters exhibited sig-
nificant levels of expression (Additional file 1: Table S2)
when compared to the pET28-lux negative control. Under
the described culture conditions, the heterologous PsxtD,
PsxtP, and PsxtPER1 promoters mediated the highest levels
of luciferase expression in E. coli (Additional file 1: Table
S3). There was a statistically significant difference (p <
0.0001) between the highest performing promoter PsxtD
and all the other promoters, as well as the controls (sxtO
and pET28-lux) (Additional file 1: Table S4).
The promoter responsible for the transcription of
orf24 and the second promoter of sxtPER, PsxtPER2
were weaker than the other promoters, but still signifi-
cantly stronger than the controls (Fig. 3a). The incorpor-
ation of both promoters into the lux expression
constructs resulted in a 12–27-fold increase in luciferase
expression over sxtO-lux (Fig. 3b), and 810–1770-fold
increase in luciferase expression over the pET28-lux
control. These results indicate that the promoters are ac-
tive, albeit weaker than the other three promoters.
The activity of sxt promoters in Synechocystis sp. PCC
6803
Four sxt promoters were active in Synechocystis sp. PCC
6803 (Fig. 4). Unpaired t-tests showed that expression of
Fig. 3 Heterologous expression from of luciferase from sxt promoters in E. coli DH5α. a Luciferase expression was normalised to the optical density, OD600. The
activity of five promoters was tested: PsxtD, PsxtP, PsxtPER1, Porf24, and PsxtPER2. An intergenic sxtO sequence was used as the non-promoter control. The
highest RLU/OD for the E. coli DH5α strains expressing luxCDABE. (*) Denotes statistically significant differences (p<0.0001) between the E. coli DH5α strains and
the pET28-lux control in unpaired t-tests. b Expression relative to the sxtO-lux control. The mean normalised luciferase expression for each promoter was divided
by the mean normalised expression of sxtO. The three strongest promoters (PsxtD, PsxtP, PsxtPER) exhibit between 1000 and 9500 fold higher levels of luciferase
expression over the sxtO control. The Porf24 and PsxtPER2 promoters had only a 12 and 27-fold increase in expression, respectively
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luciferase from the PsxtP, PsxtPER1, and Porf24 were
significantly different to expression in the control strain,
while expression from PsxtD was not statistically differ-
ent to the control strain (P < 0.05; Additional file 1:
Table S5).
The sxtD promoter regulates the transcription of op-
eron 1 of the D. circinale sxt cluster, which carries the
core biosynthetic genes, including the polyketide
synthase-like enzyme, sxtA. Strains harbouring PsxtD
had very low luciferase expression levels that were only
1.3-fold higher than expression levels in the promoter-
less control strain (Additional file 1: Table S6), and were
statistically lower than the other 3 promoters (Additional
file 1: Table S7). The lack of statistically significant ex-
pression from PsxtD indicates the promoter as the only
candidate for exchange for heterologous expression of
PSTs in Synechocystis sp. PCC 6803. PsxtP and Porf24
mediated consistent levels of luciferase expression per
OD730 throughout the experiment (Fig. 4b) PsxtPER1
mediated expression levels that were initially up to
three-fold higher than PsxtP, however, the rate of ex-
pression decreased over the course of growth.
Discussion
Information regarding the transcriptional elements of
cyanobacterial secondary metabolite biosynthesis is an
essential first step in both understanding how these me-
tabolites may be regulated within the native producers
as well as harnessing these genes for future heterologous
expression experiments. Here, we targeted the transcrip-
tional units of the D. circinale AWQC131C sxt BGC and
measured promoter activity within two possible future
heterologous hosts, E. coli and Synechocystis.
The entire D. circinale AWQC131C sxt cluster was
found to be transcribed on a total of five transcriptional
units from two bidirectional promoter sites. The isolated
promoters all contained a − 10 Pribnow box, as expected,
but sporadically contained other transcriptional elements
including the − 35 hexamer, UP element and RBS, which
is commonly observed in cyanobacteria [30, 49, 50]. A
further feature was the identification of a second pro-
moter region initiating transcription of the proposed
permease SxtPER. One of these included an intragenic
promoter region, which results in the expression of a
257 aa truncated isoform of SxtPER. While uncommon,
the use of a second TSS to produce two protein isoforms
has previously been reported [51]. For example, the bac-
terocin colicin V is secreted by a membrane transporter,
where both the full length CvaA and shorter CvaA* pro-
teins, translated from the same cvaA gene, are both
required for optimal excretion [52]. Interestingly,
BLASTp analysis revealed that a complete RhaT super
domain of the drug/metabolite transporter family [53] is
present within both isoforms of the protein. The larger
encoded protein contains additional sequence at the N-
terminus. While our previous proteomics experiments in
D. circinale were unable to detect both isoforms of
SxtPER protein under standard conditions, further
Fig. 4 Heterologous expression of luciferase from sxt promoters in Synechocystis sp. PCC 6803. a Luciferase expression from the four main sxt promoters in
Synechocystis sp. PCC 6803. The highest RLU/OD for the Synechocystis sp.PCC 6803 strains expressing luxCDABE. (*) Denotes statistically significant differences
(p<0.05) between the Synechocystis sp. PCC 6803 strains and the Synechcocystis sp. PCC 6803-lx control in unpaired t-tests. b Normalised luciferase expression
over time in Synechocystis PCC6803. RLU/OD730 over 400 h of growth. PsxtD normalised expression was low. PsxtP and Porf24 had consistent levels of luciferase
expression. PsxtPER showed high initial expression that declined over growth to expression reach levels similar to PsxtP and Porf24
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experiments are required to determine if the two iso-
forms of the proteins are required for excretion of PST
in D. circinale.
The expression of PsxtP is an interesting example of the
promoter elements required for heterologous expression
of cyanobacterial promoters in E. coli. PsxtP does not
seem to have a discernible − 35 binding region yet does
have a RBS and promoted high expression levels in E. coli.
Previous studies have shown that while the distance be-
tween the − 10 and − 35 sequences can effect transcription
in cyanobacteria, the − 35 hexamer is not always required
[54–56]. Thus, the competing preferences between the
TSS sequence and position, taken together with other
elements of the promoter such as − 10, and − 35
sequences, transcription factors, the sequence length be-
tween the − 10 and − 35 regions, and the RBS, highlights
the complexity of transcriptional regulation and shows the
importance of experimental validation of promoter activa-
tion data to further improve bioinformatics databases.
It was found that he expression levels of PsxtPER1 ini-
tiated at a high level but decreased over the course of
growth. This indicates the majority of toxins could be
exported from the cell early in culture and retained in
the cell as the culture progresses. This would allow fu-
ture research to optimise PST extraction at different cul-
ture stages, either from the cell free component or the
cell mass. Alternatively, since PsxtPER1 is active at the
early growth stages within the heterologous host, it
could be a target for repression to limit toxin export and
therefore retaining toxin within the cell. This will in-
crease the efficiency of toxin isolation from the cell
biomass.
It is known that gene expression levels will have sig-
nificant impact on the amount of PST molecule pro-
duced. Here, the promoters that regulate PST
biosynthesis mediated lowered expression of luciferase
in Synechocystis sp. PCC 6803 compared to E. coli. The
significant decrease in luciferase expression by the
cyanobacterial promoters in Synechocystis sp. PCC 6803
has previously been observed in studies of the zinc indu-
cible promoter, Psmt, from Synechococcus sp. PCC7002.
Psmt mediated higher levels of protein synthesis and
therefore higher levels of ethylene production in E. coli,
compared to Synechocystis sp. PCC 6803, which only
produced residual levels [57]. Conversely, high expres-
sion levels impacted lynbyatoxin biosynthesis in E. coli.
Heterologous expression of lyngbyatoxin (ltxA-D) in E.
coli was only successful when the strong T7 phage pro-
moter was replaced with the weaker PtetO promoter
[27]. PtetO has since been exploited for the heterologous
expression of multiple cyanobacterial BGCs in E. coli
[21, 22, 25]. Subsequent heterologous expression of lyng-
byatoxin in Anabaena using non-native promoters was
more successful than the E. coli system while expression
from the native promoter did not occur in either case
[23]. Together, these results suggest that native pro-
moters are recognised differently in heterologous hosts
and that while successful transcription of cyanobacterial
BGCs in heterologous hosts is important, other factors
play a role in the efficiency of the host production of
secondary metabolites. This study has identified each of
the five native sxt promoters and established through
the use of the lux reporter, which of those were recog-
nised in both E. coli and Synechocystis.
Conclusion
PSTs have a range of biomedical applications and thus
heterologous expression of the sxt BGC should be ex-
plored as a potential tool for the characterisation,
manipulation and sustainable production of these com-
pounds. Heterologous expression of cyanobacterial nat-
ural product BGCs has had mixed success in the past
and further characterisation of cyanobacterial promoters
is required for successful expression of complex biosyn-
thetic pathways such as the PST biosynthetic pathway.
This study identified five putative sxt promoters in D.
circinale AWQC131C and tested their activity in E. coli
and Synechocystis sp. PCC 6803. In E. coli, PsxtD, PsxtP
and PsxtPER1 promoted luciferase expression while
Porf24 was significantly weaker. Further, if Synechocystis
sp. PCC6803 is to be used as a host, the inactive PsxtD
should be replaced by host-compatible promoters. Suc-
cessfully manipulating the sxt BGC within a heterol-
ogous host at the transcription level is the first step to
efficiently access the PSTs for a range of biotechno-
logical applications.
Methods
Strains and culture conditions
D. circinale AWQC131C was maintained in Jaworski’s
medium (JM) [58] at 24 °C ± 1 °C and illuminated with
11 μmol m− 2 s− 1 of photons on a 12:12 h light/dark
cycle. Synechocystis sp. PCC 6803 was maintained in
BG11 medium supplemented with 100 μg mL− 1 spec-
tinomycin when required, at 30 °C under constant illu-
mination. Unless otherwise specified, E. coli strains
(Table 2) were maintained in Luria broth or on agar
plates supplemented with 100 μg mL− 1 ampicillin or
50 μg mL− 1 kanamycin and grown at 37 °C.
Total RNA extraction, cDNA synthesis and transcriptional
analysis
To extract high quality total RNA, cell pellets were snap-
frozen in liquid nitrogen and ground into a fine powder
with a mortar and pestle prior to extraction with the
RNeasy Plant Mini kit (QIAGEN). Residual genomic (g)
DNA was removed from total RNA samples using
TURBO DNA-free™ DNase as described by the
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manufacturer (Ambion). Removal of contaminating
gDNA was confirmed via PCR with the 27F/809R PCR
primer set targeting the cyanobacterial 16S rRNA gene
[60]. RNA quality was also checked via formaldehyde gel
electrophoresis, while gDNA was checked by agarose gel
electrophoresis.
The Superscript® III First Strand synthesis system
(Invitrogen) was used to reverse transcribe 1 μg of total
RNA primed with an antisense gene-specific primer
(GSP). Transcriptional units were determined by PCR
amplification in a 20 μL reaction mixture containing 2.5
mM MgCl2, 1 × PCR buffer (Fisher Biotec, Geneworks),
10 pmol dNTPs (Austral Scientific), 10 pmol of GSP, 1 U
of Taq polymerase (Fisher Biotec, Geneworks) and sterile
Milli-Q water. Thermal cycling was performed in a Bio-
Rad 96-well iCycler (Bio-Rad) and began with an initial
denaturation cycle of 95 °C for 4min, followed by 35 cy-
cles of DNA denaturation at 95 °C for 20 s and primer an-
nealing at 55 °C for 20 s. DNA strand extension was
altered to 1min for every 1 kb of amplified product. A
final extension at 72 °C for 7min and a final holding
temperature of 4 °C completed the thermal cycling. Each
reaction contained cDNA as the template and two primers
(Additional file 1: Table S8), which were designed to target
an adjacent gene. Amplification was observed if the two
adjacent genes were located on the same mRNA tran-
script. The positive control for each PCR contained
gDNA. Two negative control reactions were performed by
adding template from a cDNA synthesis reaction, the first
omitting reverse transcriptase and the second reaction
omitting a nucleic acid template.
Isolation of D. circinale AWQC131C sxt biosynthetic gene
cluster transcription start sites (TSS) and promoters using
5′ rapid amplification of cDNA ends (5′RACE)
To isolate the promoter of each transcriptional unit, TSSs
were localised with the FirstChoice® RLM-RACE kit for 5′
RACE (Ambion) with 10 μg total RNA as starting mater-
ial. The 5′ RACE adapter was ligated directly onto RNA
followed by reverse transcription cDNA synthesis. First
round PCR reactions were performed using a 5′ outer
adapter primer in conjunction with four reverse GSPs at
approximately 50–100 bp intervals (Additional file 1:
Figure S3, Table S9). Reactions containing amplified prod-
ucts from the first round PCR became the template for
second round nested PCR containing a 5′ adapter inner
primer in conjunction with the same four reverse primers.
Amplicons of interest were analysed on a 2% (w/v) agarose
gel and purified using a QIAquick spin gel extraction kit
(QIAGEN). Purified PCR products were then cloned into
the pGEM-T Easy vector (Promega) and sequenced using
an ABI 3730 capillary sequencer at the Ramaciotti Centre
for Genomics, UNSW.
Cloning and transformation
The TOPO TA cloning® kit (Invitrogen) and the
pGEM®-T Easy Vector kit (Promega) were used for the
cloning and transformation of E. coli (Table 2). Cloning
with the TOPO TA cloning® kit involved setting up a
ligation reaction containing 4 μL of PCR product, 1 μL
of Invitrogen salt solution (1.2M NaCl, 0.06M MgCl2)
and 10 ng pCR®2.1-TOPO® plasmid DNA (Invitrogen).
The ligation reaction was incubated for 20 min at room
Table 2 Strains and plasmids
Organism Purpose Ref.
DH5α Expression host of lux reporter assay Promega





Organism harbouring native sxt cluster [34]
Synechocystis
sp. PCC6803
Expression host of lux reporter assay
Synechocystis
SXL7
ΔphbC:: PsxtD-luxCDABE - SpecR This study
Synechocystis
SXL8
ΔphbC:: PsxtP-luxCDABE - SpecR This study
Synechocystis
SXL9
ΔphbC:: PsxtPER1-luxCDABE - SpecR This study
Synechocystis
SXL10
ΔphbC:: Porf24-luxCDABE - SpecR This study
Synechocystis
SXL11
ΔphbC:: luxCDABE - SpecR This study
Plasmids Purpose Ref.
pCR™2.1 TOPO Cloning and sequencing of 5′ RACE
TSS products
Invitrogen
pGEM T-Easy Cloning and sequencing of 5′ RACE
TSS products
Promega
pET28b Cloning and expression of sxt
promoters
Novagen
pSYN_6.3 Cloning and transformation of sxt
promoters in Synehcocystis sp. PCC
6803
Unpublished
pLUX NS II luxCDABE [59]
pSXL1 pET28b::PsxtD-luxCDABE This study
pSXL2 pET28b::PsxtP-luxCDABE This study
pSXL3 pET28b::PsxtPER1-luxCDABE This study
pSXL4 pET28b::Porf24-luxCDABE This study
pSXL5 pET28b::PsxtPER2-luxCDABE This study
pSXL6 pET28-sxtO-luxCDABE This study
pET28-lux pET28-luxCDABE This study
pSXL7 pSYN_6.3::PsxtD- luxCDABE This study
pSXL8 pSYN_6.3::PsxtP- luxCDABE This study
pSXL9 pSYN_6.3::PsxtPER1- luxCDABE This study
pSXL10 pSYN_6.3::Porf24- luxCDABE This study
pSXL11 pSYN_6.3::luxCDABE This study
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temperature and was then ready for transformation. The
pGEM®-T Easy vector ligation reaction contained 1 ×
rapid ligation buffer (Promega), 50 ng of pGEM®-T Easy
vector DNA (Promega), 3 Weiss U of T4 DNA ligase
(Promega) and 3 μL of PCR product. The ligation reac-
tion was left to incubate overnight at 4 °C and was then
ready for transformation. Positive transformants were
selected by blue and white colony screening and the
presence of a cloned insert was confirmed by colony
PCR using either the primer sets M13F and M13R
(pCR®2.1-TOPO) or T7F and M13R (pGEM-T Easy).
Plasmids containing an insert were then sequenced.
Engineering the sxt promoter-luciferase reporter
constructs for expression in E. coli DH5α
Five promoters (PsxtD, PsxtP, PsxtPER1, Porf24,
PsxtPER2) and a non-promoter region within the sxtO
open reading frame were cloned into the pET28b expres-
sion vector along with the luciferase reporter (luxCDABE)
operon from Photorhabdus luminescens (Additional file 1:
Figure S4A). The luciferase operon (luxCDABE) was amp-
lified from the pLuxNSII plasmid [59] via PCR (denatur-
ation at 98 °C for 3 min, followed by 30 cycles of
denaturation at 98 °C for 15 s, annealing step at 60 °C for
20s, extension at 72 °C for 30s/kb, and a final extension at
72 °C for 10min), and the pET28b backbone was also
PCR amplified to remove the T7 promoter region. All
primers were designed using the NEBuilder assembly tool
(Additional file 1: Table S10). Double-stranded PCR frag-
ments were amplified using the KAPA HiFi Hotstart DNA
polymerase (KAPA biosystems). The pET28b backbone,
sxt promoter (Psxt), and lux operon were assembled using
the Gibson assembly master mix (NEB) [61], and incu-
bated at 50 °C, for 1 h. The reaction was transformed into
chemically competent E. coli DH5α and positive colonies
selected as above.
Engineering the sxt promoter-luciferase reporter
constructs for expression in Synechocystis sp. PCC 6803
The Psxt-lux integration vector was engineered through
classical restriction/ligation cloning using the restriction
enzymes NotI and KpnI (NEB). The Psxt-lux fragments
were amplified from the pET28b-P-lux vectors using the
lacI-P-lux_NotI_F, and lacI-P-lux_KpnI_R primers (Add-
itional file 1: Table S10). Linear DNA fragments were
digested, purified and ligated into the pSYN_6.3 vector
(Additional file 1: Figure S4B) using T4 DNA ligase at
22 °C for 1 h, followed by transformation into E. coli
DH5α and colony screening. Plasmid constructs were
confirmed by terminal-end sequencing.
The integration of the Psxt-lux fragments into the
Synechocystis sp. PCC 6803 genome (Additional file 1:
Figure S4C) was achieved via the natural competence of
the host [62]. Synechocystis sp. PCC 6803 was grown at
30 °C, with shaking at 100 rpm, under constant light
until exponential phase, and used to inoculate a 50 mL
BG11 medium to an initial OD730 of 0.05. After ~ 4 days
of photoautotrophic growth, the cells reached an OD730
of 0.5, and were harvested by centrifugation at 2750 g for
5 min. Cells were resuspended in 2 mL of fresh BG11
medium, divided into 0.5 mL aliquots (OD730 of 2.5),
combined with 10 μg of DNA and incubated at 30 °C for
6 h. A sterile Immobilon Transfer membrane (Merk
Millipore) was placed on each BG11 agar plate, overlaid
with 200 μL of the transformation mixture and incu-
bated for 12 h under constant illumination at 30 °C.
Membranes were transferred to BG11 agar plates con-
taining 25 μg mL− 1 spectinomycin. The plates were incu-
bated for a further 2 days at 30 °C under constant
illumination, before the membrane was transferred to
plates containing 50 μg mL− 1 spectinomycin and incu-
bated for a further 7–10 days until colonies become vis-
ible. Recombinant Synechocystis sp. PCC 6803 colonies
were picked and streaked onto BG11 agar plates supple-
mented with 100 μg mL− 1 spectinomycin and subcul-
tured a further three times to achieve integration of the
cloned reporter fragment and full chromosomal segrega-
tion. Transformants were confirmed using the PhaCaF
and PhaCbR PCR primers (Additional file 1: Table S10).
Activity of sxt promoters in E. coli DH5α
Promoter-luciferase reporter constructs were transformed
into E. coli DH5α and grown on M9 minimal medium
supplemented with 50 μgmL− 1 kanamycin at 37 °C for 24
h. Bioluminescence (RLU) and optical density measure-
ments were measured at one-hour intervals until the
OD600 reached 0.8. A final measurement was taken at 24
h. The strength of each promoter was measured as the
highest bioluminescence, normalised to OD600. One-way
ANOVA (Graphpad Prism 7) was used to calculate any
statistical differences between the promoters. Unpaired t-
tests were also used to determine the statistical differences
between the strains and the control.
Activity of sxt promoters in Synechocystis sp. PCC 6803
Promoter-luciferase reporter constructs were trans-
formed into Synechocystis sp. PCC 6803 strains, which
were inoculated into BG11 medium supplemented with
100 μg mL− 1 of spectinomycin and grown at 30 °C with
shaking under constant illumination. Optical density and
relative light units (RLU) were measured every 24 h for
400 h. Promoter strength was measured by determining
the highest RLU per OD730. One-way ANOVA (Graph-
pad Prism 7) was used to calculate any statistical differ-
ences between the promoters. Unpaired t-tests were also
used to determine the statistical differences between the
strains and the control.
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Additional file 1. Contains supplimentary data including results for
transcript analysis and TSS sequencing, nested PCR to determine TSS,
cloning strategy, transcriptional terminator prediction, statistical analysis,
primer sequences, as well as all vector sequences with corresponding
vector maps.
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